Australia Diagnostic Imaging Market: Size, Share & Forecast 2025-2033

Australia Diagnostic Imaging Market Overview

Market Size in 2024: USD 977.20 Million

Market Size in 2033: USD 1,717.28 Million

Market Growth Rate 2025-2033: 5.80%

According to IMARC Group's latest research publication, "Australia Diagnostic Imaging Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The Australia diagnostic imaging market size was valued at USD 977.20 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 1,717.28 Million by 2033, exhibiting a CAGR of 5.80% during 2025-2033.

How AI is Reshaping the Future of Australia Diagnostic Imaging Market

• $25 Million Mobile CT Revolutionary Contract: The US Advanced Research Projects Agency for Health (ARPA-H) awarded Micro-X, an Australian X-ray technology business, a development contract worth up to USD 16.4 million (AUD $25 million) in February 2025 to create the first full-body portable mobile CT scanner in history. The Platform Accelerating Rural Access to Distributed and Integrated Medical Care (PARADIGM) initiative aims to revolutionize remote area diagnostics through lightweight, transportable whole-body imaging enabling rural and regional hospitals unprecedented access to advanced technology bridging geographic healthcare disparities.

• 25.08% Oncology Market Leadership: Oncology applications lead Australia's diagnostic imaging market commanding 25.08% of total 2024 revenue, driven by critical demand for early cancer detection, staging, treatment planning, and monitoring capabilities. Advanced imaging modalities including PET-CT, functional MRI, and AI-powered diagnostic systems enable molecular-level disease identification supporting personalized cancer treatment strategies with precision medicine integration improving outcomes across diverse oncology specialties.

• TGA-Approved LungVision AI System: Body Vision Medical achieved breakthrough in March 2025 when Therapeutic Goods Administration (TGA) approved their LungVision advanced imaging system representing AI-powered intraoperative imaging innovation worldwide. This approval milestone accelerates company goal to increase early and accurate lung cancer diagnosis globally through real-time surgical guidance technology integrated with diagnostic imaging platforms supporting treatment optimization and improved clinical outcomes.

• Practice-Based MRI Licensing Expansion: Australia's Medicare initiated transition to practice-based MRI licensing from 2025, expanding eligible scanner access beyond facility-based limitations and improving regional availability of high-quality diagnostic imaging. This regulatory evolution democratizes access to advanced MRI technology across independent practices and distributed healthcare settings, reducing patient travel requirements while supporting equitable diagnostic access across metropolitan and regional populations.

• AI-Integrated Precision Medicine Revolution: Artificial intelligence integration signifies transformative shift in diagnostic imaging practices enhancing efficiency and diagnostic precision through automated image interpretation, anomaly detection, and treatment planning support. AI-assisted systems enable radiologists to process increased case volumes while improving accuracy, supporting integration with genetic and laboratory data alongside imaging analytics for personalized clinical decision-making advancing precision medicine adoption across oncology, cardiology, neurology, and orthopedic specialties.

Grab a sample PDF of this report: https://www.imarcgroup.com/australia-diagnostic-imaging-market/requestsample

Australia Diagnostic Imaging Market Trends & Drivers:

Australia's diagnostic imaging market is experiencing transformative growth driven by rapid technological advancements including AI integration, 3D imaging, PET-CT, MRI, and low-dose radiation systems improving accuracy, efficiency, and safety of diagnostic procedures. These innovations enable earlier and more precise detection of cancer, cardiovascular disease, and neurological disorders, with Australia's robust research and development ecosystem supporting adoption of cutting-edge solutions. Digital tools including teleradiology and cloud-based imaging platforms enhance data sharing and remote diagnostics, while both public and private providers invest in next-generation equipment driving demand across urban and regional healthcare settings.

Rising incidence of chronic and age-related diseases combined with aging population significantly boosts diagnostic imaging demand. Elderly patients require frequent monitoring and imaging managing degenerative diseases and comorbidities, with diagnostic imaging essential for early detection, staging, and treatment planning particularly in oncology and cardiovascular care. As lifestyle-related conditions increase prevalence and life expectancy extends, health services face pressure providing accurate, timely diagnoses making imaging indispensable to Australia's preventive healthcare strategy and ongoing disease management frameworks.

Government healthcare funding through Medicare subsidies, bulk-billing practices, and capital grants significantly improves diagnostic imaging accessibility and service quality. Government initiatives supporting digital health infrastructure, healthcare facility expansion in underserved regions, and workforce training accelerate market growth while public-private partnerships bridge infrastructure gaps enabling sustainable service delivery across remote and rural areas. Integration with precision medicine through imaging data informing personalized treatment strategies alongside genetic and laboratory data advances personalized healthcare approaches driving ongoing market expansion.

Australia Diagnostic Imaging Market Industry Segmentation:

The report has segmented the market into the following categories:

Modality Insights:

• MRI (Low and Mid Field MRI Systems, High Field MRI Systems, Very High and Ultra High Field MRI Systems)

• Computed Tomography (Low-end Scanners, Mid-range Scanners, High-end Scanners)

• Ultrasound (2D Ultrasound, 3D Ultrasound, Others)

• X-Ray (Analog Systems, Digital Systems)

• Nuclear Imaging (Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT))

• Others

Application Insights:

• Cardiology

• Oncology

• Neurology

• Orthopedics

• Gastroenterology

• Gynecology

• Others

End User Insights:

• Hospitals

• Diagnostic Centers

• Others

Breakup by Region:

• Australia Capital Territory & New South Wales

• Victoria & Tasmania

• Queensland

• Northern Territory & Southern Australia

• Western Australia

Recent News and Developments in Australia Diagnostic Imaging Market

• February 2025: US Advanced Research Projects Agency for Health (ARPA-H) awarded Micro-X USD 16.4 million (AUD $25 million) development contract to create first full-body portable mobile CT scanner through PARADIGM initiative. This groundbreaking technology will revolutionize rural and regional diagnostic capabilities, delivering advanced imaging to underserved areas and dramatically improving healthcare access across geographically dispersed Australian populations.

• March 2025: Therapeutic Goods Administration (TGA) approved Body Vision Medical's LungVision advanced imaging system representing major breakthrough in AI-powered intraoperative imaging technology. This approval accelerates company's global mission improving early and accurate lung cancer diagnosis through real-time surgical guidance integrated with advanced diagnostic imaging supporting precision oncology treatment planning and patient outcomes.

• 2025: Australia's Medicare transitioned to practice-based MRI licensing expanding eligible scanner access beyond traditional facility-based limitations. This regulatory evolution democratizes high-quality MRI access across independent practices and distributed healthcare settings, reducing patient travel requirements while supporting equitable diagnostic imaging access across metropolitan and regional populations improving healthcare equity.

• 2024-2025: Oncology applications commanding 25.08% of Australia diagnostic imaging market revenue reflecting critical demand for cancer detection, staging, and treatment planning. Advanced imaging modalities including PET-CT, functional MRI, and AI-powered systems enable molecular-level disease identification supporting precision medicine integration with personalized treatment strategies improving clinical outcomes across diverse oncology specialties.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Fujifilm Medical Systems, Samsung Healthcare, Mindray Bio-Medical Electronics, Micro-X Limited, Body Vision Medical, Analogic Corporation, and regional diagnostic imaging providers and independent radiology centers delivering comprehensive imaging services across hospitals, diagnostic centers, and distributed healthcare settings.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302